Peptide literature spans laboratory models, animal studies, pharmacology work and human clinical research. NovaMeds keeps those evidence levels distinct so product pages remain useful without turning preliminary findings into treatment claims.
In vitro research examines cells, receptors or biochemical systems under controlled laboratory conditions.
Animal and preclinical models can explore mechanisms and biological responses, but their findings do not automatically translate to people.
Human clinical research can provide more directly relevant evidence, but study design, population, endpoints and regulatory status still matter.
Mechanistic plausibility and early experimental findings should never be presented as established clinical effectiveness.
NovaMeds does not provide diagnosis, treatment recommendations, dosing protocols, administration instructions or patient-specific medical guidance. Product information and research summaries should be read as informational context only.